| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |